Measles in the United Kingdom: Can we eradicate it by 2010?

British Medical Journal

Volumn 333, Issue 7574, 2006, Pages 890-895

  Asaria, Perviz ^a   MacMahon, Eithne ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MEASLES MUMPS RUBELLA VACCINE;

BLINDNESS; CLINICAL FEATURE; DEMYELINATING DISEASE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; DRUG EFFICACY; ENCEPHALITIS; ENDEMIC DISEASE; EUROPE; FEBRILE CONVULSION; HEPATITIS; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; LABORATORY TEST; LARYNGOTRACHEOBRONCHITIS; MACULOPAPULAR RASH; MEASLES; OTITIS MEDIA; PANENCEPHALITIS; PLEOCYTOSIS; PNEUMONIA; PREGNANCY; PRIORITY JOURNAL; RETINOL DEFICIENCY; REVIEW; RNA VIRUS; RUBELLA; UNITED KINGDOM; UNITED STATES; VACCINATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL DISEASES; GREAT BRITAIN; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNIZATION PROGRAMS; INFANT; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; NERVOUS SYSTEM DISEASES; PATIENT ACCEPTANCE OF HEALTH CARE; PNEUMONIA, VIRAL; RESPIRATION DISORDERS; VACCINATION; VITAMIN A DEFICIENCY;

EID: 33750583314     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38989.445845.7C     Document Type: Review

References (26)

1. Health Protection Agency. Measles cases so far in 2006. Press statement dated 15 June 2006. www.hpa.org.uk/hpa/news/articles/press_releases/2006/ 060615_measles.htm (accessed 21 Jun 2006).
2. Health Protection Agency. Increase in measles cases in 2006, in England and Wales. Commun Dis Rep Wkly 2006;16:3. www.hpa.org.uk/cdr/archives/2006/ cdr1206.pdf (accessed 21 Jun 2006).
3. World Health Organization Europe. Eliminating measles and rubella and preventing congenital rubella infection. WHO European region strategic plan 2005-2010. Copenhagen: WHO Regional Office for Europe, 2005:1-34. www.euro.who.int/document/E87772.pdf (accessed 21 Jun 2006).
4. Gershon AA. Measles virus (rubeola). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone, 2005:2031-8.
5. World Health Organization Media Centre. Fact sheet No 286 revised March 2006. Measles, www.who.int/mediacentre/factsheets/fs286/en/print.html (accessed 21 Jun 2006).
6. Griffin DE. Measles virus. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Philadelphia: Lippincott, Williams, & Wilkins, 2001;1:1401-41.
7. Shneider-Schaulies S, ter Meulen V. Measles. In: Zuckerman AJ, Banatvala JE, Pattison JR, Griffiths PD, Schoub BD, eds. Principles and practice of clinical virology. 5th ed. Chichester: Wiley, 2004:399-426.
8. Department of Health. Measles. In: Immunisation against infectious disease. 2005:1-24. www.dh.gov.uk/assetRoot/04/12/44/88/04124488.pdf (accessed 21 Jun 2006).
9. Anderson RM, May RM. Immunisation and herd immunity. Lancet 1990;335:641-5.
10. Meissner HC, Strebel PM, Orenstein WA. Measles vaccines and the potential for worldwide eradication of measles. Pediatrics 2004;114:1065-9.
11. Health Protection Agency. Measles website. www.hpa.org.uk/infections/ topics_az/measles/menu.htm (accessed 21 Jun 2006).
12. Ramsay ME, Jin L, White J, Litton P, Cohen B, Brown D. The elimination of indigenous measles transmission in England and Wales. J Infect Dis 2003;187:S198-207.
13. Vyse AJ, Gay NJ, White JM, Ramsay ME, Brown DW, Cohen BJ, et al. Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev 2002;24:125-36.
14. Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science 2003;301:804.
15. Gay N, Ramsay M. Potential for measles transmission in London. London: Health Protection Agency Communicable Disease Surveillance Centre, 2004:1-5.
16. Department of Health. Contraindications and special considerations. In: Immunisation against infectious disease. 2006:1-7. www.dh.gov.uk/assetRoot/04/ 12/86/07/04128607.pdf (accessed 29 Jun 2006).
17. Centers for Disease Control and Infection National Immunization Programme. Measles. In: Epidemiology and prevention of vaccine-preventable diseases. The pink book. Updated 9th ed. Waldorf, USA: Public Health Foundation, 2006:125-44. www.cdc.gov/nip/publications/pink/meas.pdf (accessed 21 Jun 2006).
18. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis 2004;189:S4-16.
19. Duke T, Mgone CS. Measles: not just another viral exanthem. Lancet 2003;361:763-73.
20. Shalev-Zimels H, Weizman Z, Lotan C, Gavish D, Ackerman Z, Morag A. Extent of measles hepatitis in various ages. Hepatology 1988;8:1138-9.
21. Hussey GD, Klein M. A randomized controlled trial of vitamin A in children with severe measles. N Engl J Med 1990;323:160-4.
22. Okada H, Kobune F, Sato TA, Kohama T, Takeuchi Y, Abe T, et al. Extensive lymphopaenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol 2000;145:905-20.
23. Brown DWG, Ramsay MEB, Richards AF, Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ 1994;308:1015-7.
24. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 1992;267:1237-41.
25. Moss WJ, Monze M, Ryon JJ, Quinn TC, Griffin DE, Cutts F. Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clin Infect Dis 2002;35:189-96.
26. Siegel M. Congenital malformations following chickenpox, measles, mumps and hepatitis. Results of a cohort study. JAMA 1973;226:1521-4.